Unlock the full therapeutic potential of membrane protein targets to create transformative options for future patients
The foundation of Abilita Bio’s Drug Discovery capabilities is our EMP™ technology, which is based on the principles of directed evolution.
Enabled Membrane Proteins (EMPs™) are stability and expression enhanced variants that enable discovery and optimization of drug candidates.
© Abilita Bio, Inc. 2023 All Rights Reserved
Automated page speed optimizations for fast site performance